FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新琪安集團股份有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02573 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 55,148,894 | RMB | | | 1 RMB | | 55,148,894 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | | | 本月底結存 | | | 55,148,894 | RMB | | | 1 RMB | | 55,148,894 | | 2. 股份分類 | 普 ...

Core Insights - As of October 24, a total of 60 stocks reached their 52-week highs, with 康大食品 (00834), 五矿地产 (00230), and CMON (01792) leading in growth rates of 121.62%, 58.33%, and 43.86% respectively [1][2]. 52-Week Highs Summary - 康大食品 (00834) closed at 0.600, with a peak price of 0.820, achieving a growth rate of 121.62% [2]. - 五矿地产 (00230) closed at 0.940, with a peak price of 0.950, achieving a growth rate of 58.33% [2]. - CMON (01792) closed at 0.062, with a peak price of 0.082, achieving a growth rate of 43.86% [2]. - Other notable stocks include 圆美光电 (08311) with a growth rate of 32.65%, and 世纪联合控股 (01959) with a growth rate of 29.71% [2]. 52-Week Lows Summary - The report also highlighted stocks reaching their 52-week lows, with 能源及能量环球 (01142) showing a decline of 38.98% [3]. - 新琪安 (02573) experienced a decrease of 14.87%, while 中国信息科技 (08178) saw a decline of 12.66% [3]. - Other stocks with significant declines include 星空华文 (06698) at -7.89% and 九江银行 (06190) at -6.91% [3].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新琪安集團股份有限公司 呈交日期: 2025年10月8日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02573 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 55,148,894 | RMB | | | 1 RMB | | 55,148,894 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | | | 本月底結存 | | | 55,148,894 | RMB | | | 1 RMB | | 55,148,894 | | 2. 股份分類 | 普通 ...

Financial Performance - The total revenue for the period reached RMB 334.8 million, representing a year-on-year increase of 54.3%[10] - Gross profit amounted to RMB 77.95 million, showing a significant increase of 252.74% compared to the same period last year[10] - Revenue from food-grade and industrial-grade glycine was RMB 168.0 million, up 25.9% year-on-year[10] - Revenue from sucralose reached RMB 152.1 million, reflecting a substantial increase of 116.8% compared to the previous year[10] - The group's profit increased by 586.4% from RMB 3.6 million in the previous half-year to RMB 24.4 million[46] - Net profit for the period was RMB 24,375 thousand, compared to RMB 3,551 thousand in 2024, marking a substantial year-over-year growth[77] - Basic and diluted earnings per share increased to RMB 0.28 from RMB 0.04 in the prior year, demonstrating enhanced shareholder value[77] Assets and Liabilities - Total assets increased by 38.5% to RMB 1,125,924 thousand as of June 30, 2025, compared to RMB 812,908 thousand at the end of the previous year[23] - Current assets rose by 75.9% to RMB 693,740 thousand, accounting for 61.6% of total assets[23] - Cash and cash equivalents increased by 385.9% to RMB 250,087 thousand, compared to RMB 51,469 thousand at the end of the previous year[23] - The total value of property, plant, and equipment as of June 30, 2025, was RMB 686,798,000, up from RMB 664,242,000 as of January 1, 2025, showing ongoing investment in assets[103] - Bank borrowings increased to RMB 144,600,000 as of June 30, 2025, compared to RMB 74,700,000 at the end of 2024, reflecting a 93.4% increase[122] Research and Development - The company expanded its R&D team and center to enhance research capabilities and focus on overseas markets[15] - The company is developing new products such as algal dietary fiber and has invested in a new production facility adjacent to the existing factory in Ji'an[15] - As of June 30, 2025, the internal R&D team consisted of 46 employees, with additional experts hired to improve capacity and optimize existing products[16] - Research and development expenses rose to RMB 12,007 thousand from RMB 7,130 thousand, highlighting the company's commitment to innovation[77] Market Strategy - The company has adopted different sales strategies for glycine products targeting the U.S. market due to high tariffs imposed by the U.S. government[11] - The company plans to focus on overseas markets and expand production capacity in Thailand for sucralose and isomaltulose products[33] - Continuous development of new products, including natural ingredients like curcumin and algal dietary fiber, to align with industry trends[32] Corporate Governance - The company has adopted good corporate governance practices and has complied with the corporate governance code, except for the non-separation of the roles of Chairman and CEO[59] - The board consists of 5 executive directors, 1 non-executive director, and 3 independent non-executive directors, ensuring a balanced composition[59] - All directors and supervisors confirmed their full compliance with the standard code of conduct during the reporting period[61] Employee and Compensation - The group employed 751 staff as of June 30, 2025, with total employee compensation amounting to RMB 33.9 million for the six months ending on that date[54] - The remuneration for key management personnel was RMB 1,883,000 for the six months ended June 30, 2025, compared to RMB 1,503,000 for the same period in 2024, marking a rise of 25.3%[140] Risk Management - The group has established a risk management strategy to identify and analyze various risks, ensuring they remain within acceptable limits[47] - The company is closely monitoring the U.S. government's latest tariff policies, which may have a minor adverse impact on the sale of glycine to the U.S.[48] Future Investments - 21.3% of the net proceeds will be allocated to the construction of the isomaltulose production line in Thailand, with an expected remaining amount of HKD 35.0 million by the end of 2025[58] - 55.3% of the net proceeds are designated for the production of algal dietary fiber and serine, with an expected remaining amount of HKD 90.8 million by the end of 2026[58] - 13.4% of the net proceeds will enhance R&D capabilities, with an expected remaining amount of HKD 22.0 million by the end of 2026[58] - The group has no significant investments or acquisitions as of June 30, 2025, with no plans for major future investments or capital asset projects[55]

Newtrend Group Holding Co., Ltd. 新琪安集團股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) ( 於中華人民共和國註冊成立的股份有限公司 ) （Stock Code 股份代號：2573） 26 September 2025 Dear Non-registered Shareholder, Arrangement of Electronic Dissemination of Corporate Communications Pursuant to the Rules Governing The Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") effective from 31 December 2023, the Company has adopted the arrangement to dissemin ...

發佈公司通訊 根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第 2.07A 條 1 以及新琪安 集團股份有限公司（「本公司」）的公司組織章程細則，本公司將以電子通訊方式向其股東 3 發佈本公 司日後的公司通訊（「公司通訊 2」），並僅應股東要求向其寄發印刷本形式的公司通訊。 本公司不會向股東發出公司通訊網站版本 6 的登載通知。本公司鼓勵股東主動留意網站上所有日後 的公司通訊的登載情況，並自行瀏覽公司通訊的網站版本。 向本公司提供股東電子郵箱地址 為了支援通過電子郵件進行電子通訊，本公司建議股東隨時向本公司香港股份過戶登記處（「股份過戶 登記處」）卓佳證券登記有限公司（地址為香港夏慤道 16 號遠東金融中心 17 樓）發出合理書面通知， 或發送電子郵件至 2573-ecom@vistra.com 向本公司提供其電子郵箱地址。 股東有責任提供有效的電子郵箱地址。若本公司沒有獲取股東的電子郵箱地址或所提供的電子郵箱地址 無效，本公司將按照上述安排行事。若本公司向股東提供的電子郵箱地址發送可供採取行動的公司通訊 而未收到任何「未送達信息」，則本公司將被視為已遵守上市規則。 安排 1. 可供採取 ...

登記股東之名稱及地址 Newtrend Group Holding Co., Ltd. 新琪安集團股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) ( 於中華人民共和國註冊成立的股份有限公司 ) （Stock Code 股份代號：2573） 2025 年 9 月 26 日 尊敬的股東 發佈公司通訊之安排 簡介 根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第 2.07A 條 1 以及新琪安集團股份 有限公司（「本公司」）的公司章程細則，本公司將以電子通訊方式向其股東 3 發佈本公司日後的公司通訊 （「公司通訊 2」），並僅應股東要求向其寄發印刷本形式的公司通訊。 安排 1. 可供採取行動的公司通訊 4 本公司將以電子通訊方式（通過電子郵件）向股東個別地發送可供採取行動的公司通訊。如果本公司沒有獲 取股東的電子郵箱地址或其提供的電子郵箱地址無效 5，本公司將以印刷本形式向其發送可供採取行動的公 司通訊，連同一份索取股東有效電子郵箱地址的表格 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | N/A | 說明 | 內資股 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 41,082,340 RMB | | | 1 RMB | | 41,082,340 | | 增加 / 減少 (-) | | | 0 | | | RMB | | | | 本月底結存 | | | 41,082,340 RMB | | | 1 RMB | | 41,082,340 | 本月底法定/註冊股本總額： RMB 96,231,234 第 1 頁 共 10 頁 v 1.1.1 II. 已發行股份及/或庫存股份變動 ...

Core Viewpoint - The Hong Kong IPO market is active, with 57 new listings and a total fundraising amount of 131.9 billion HKD as of August 25. However, many companies face challenges in meeting both domestic and Hong Kong regulatory requirements for listing [1]. Group 1: Hong Kong IPO Overview - As of August 25, 2023, there have been 57 new IPOs on the Hong Kong Stock Exchange, raising a total of 131.9 billion HKD [1]. - There are currently 211 companies that have submitted applications for listing in Hong Kong [1]. Group 2: Listing Challenges - Companies looking to list in Hong Kong must comply with both domestic laws and Hong Kong's regulatory framework, making the IPO preparation process complex and demanding [1]. Group 3: Resources for Companies - A compilation of Hong Kong listing rules and disclosure documents for domestic companies planning to list in Hong Kong has been organized to assist businesses in understanding the latest regulatory dynamics [1].

Group 1 - The core viewpoint of the article highlights the significant growth in revenue and profit for the sweetener manufacturer, New Qi'an Technology Co., Ltd., in the first half of the year [3] - The company reported a revenue of 335 million yuan (47 million USD), representing a year-on-year increase of 54.3% [3] - Net profit surged to 24.38 million yuan, a remarkable increase of 586.4% compared to 3.55 million yuan in the same period last year [3] Group 2 - The growth in performance is primarily attributed to the increase in sales of core products, with revenue from sucralose reaching 152 million yuan, a year-on-year increase of 116.8% [3] - Revenue from food-grade and industrial-grade glycine totaled 168 million yuan, reflecting a year-on-year increase of 25.9% [3] - The management indicated that high tariffs imposed by the U.S. on Chinese glycine prompted the company to expand overseas sales through its factory in Indonesia, while a new factory in Thailand further boosted sucralose exports [3] Group 3 - As of June 30, the company's total assets were approximately 1.126 billion yuan, an increase of 38.5% compared to the end of last year [3] - Cash reserves reached 250 million yuan, and the debt ratio decreased to 39.7% [3] - The gross profit margin significantly improved from 10.2% in the same period last year to 23.3% [3] Group 4 - The company's stock price opened higher on Monday, reaching 13.19 HKD, an increase of 1.70% by midday [3]